Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBatm Advanced Regulatory News (BVC)

Share Price Information for Batm Advanced (BVC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.95
Bid: 18.25
Ask: 18.80
Change: 0.35 (1.88%)
Spread: 0.55 (3.014%)
Open: 18.20
High: 18.95
Low: 18.20
Prev. Close: 18.60
BVC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Launch of mobile agri-waste treatment solution

7 Mar 2017 07:00

RNS Number : 6790Y
BATM Advanced Communications Ld
07 March 2017
 

7 March 2017

 

BATM Advanced Communications Limited

("BATM" or "the Group")

 

BATM launches World's first Mobile Agri-Waste Solution and Wins $2.5m Contract

 

BATM Advanced Communications Limited (LSE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, is pleased to announce that its Pathogenic Waste Treatment and Sterilisation unit has launched the world's first mobile agri-waste treatment solution and has been awarded a contract worth $2.5m. BATM has received an advance payment of $1m with delivery of the product expected to commence during H2 2017 and due to complete in Q1 2018.

 

The contract is for the delivery of a mobile unit giving the customer the ability to deploy the solution for the safe disposal of mass poultry affected by disease and illness. Poultry affected by disease and illness cannot be transported from their location and are disposed of on-site either via burning or burial. The treatment process is completely eco-friendly with no hazardous materials or chemicals used and creates no odour.

 

This order follows the successful installation and operation over the last several months of an agri-waste treatment solution at a major rendering site. BATM received two significant orders for stationary units, one for treating poultry and another contract to treat bovine remains. Both contracts are advancing well with full commercial deployment of the first one expected in H1 2017.

 

BATM's agri-waste treatment solutions utilise the Group's proprietary medical sterilisation solution ("ISS") in the rendering process, allowing the safe treatment of animal remains to generate valuable protein and fat. These proteins and fats can be used for animal or fish food and provide an additional source of revenue for the Group's customers.

 

Dr. Zvi Marom, CEO of BATM, said: "We are very pleased to have received this significant order for our mobile agri-waste treatment solution from such a major customer. Our agri-waste solution is unique and, in addition to its cost advantages and savings, provides a perfect ecological solution. We believe that making our solution mobile presents our customers with a new, efficient and eco-friendly way of dealing with animal diseases.

 

"Our ISS technology has become the leading biologic and pathogenic waste solution in the medical market and is now deployed by more than 400 hospitals. As demonstrated by our agri-waste solutions, we are finding new applications for this technology on a much larger scale in both the biopharma and agricultural fields. Our ISS solution recently received a patent in the US and we expect our agri-waste solution to do the same in due course.

 

"BATM management expects to receive more orders based on the ISS technology this year."

 

 

Enquiries:

 

BATM Advanced Communications

 

Dr Zvi Marom, Chief Executive Officer

+972 9866 2525

Moti Nagar, Chief Financial Officer

 

 

 

finnCap

 

Stuart Andrews, Scott Mathieson

+44 20 7220 0500

 

 

Shore Capital

 

Mark Percy, Anita Ghanekar

+44 20 7408 4050 

 

 

Luther Pendragon

 

Harry Chathli, Claire Norbury

+44 20 7618 9100

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLFFELVFIRIID
Date   Source Headline
18th Apr 20247:00 amRNSBATM to deliver Edgility to new Tier 1 customer
8th Apr 20247:00 amRNSBATM awarded new Edgility contract from Cemex
3rd Apr 20247:00 amRNSAnnual Financial Report
26th Mar 20247:00 amRNSBATM receives $2.3m cyber security orders
12th Mar 20247:00 amRNSFull Year Results
29th Feb 20247:00 amRNSNotice of Results
2nd Jan 20247:00 amRNSTotal Voting Rights
30th Nov 20237:03 amRNSBlock Listing Application
27th Nov 20237:00 amRNSBlock Listing Interim Review
30th Oct 20237:00 amRNSBATM receives $3m cyber security order
23rd Oct 20237:00 amRNSADOR Diagnostics secures $7.5m investment
16th Oct 20233:30 pmRNSHolding(s) in Company
16th Oct 20233:30 pmRNSHolding(s) in Company
16th Oct 20237:00 amRNSNew Edgility order for US Emergency Services
9th Oct 20237:00 amRNSResponse to recent developments in Israel
6th Sep 20237:00 amRNSBATM receives $3.4m cyber security contract
29th Aug 20237:00 amRNSInterim Results
13th Jul 202311:30 amRNSResult of AGM and Director Appointment
8th Jun 20237:00 amRNSNotice of Annual General Meeting
6th Jun 20237:00 amRNSCapital Markets Day
5th Jun 20237:00 amRNSNew contract win for Edgility
10th May 20232:30 pmRNSCapital Markets Day and Investor Presentation
17th Apr 20237:00 amRNSEdgility rollout progressing ahead of schedule
4th Apr 20233:30 pmRNSAnnual Financial Report
6th Mar 20237:00 amRNSFull Year Results
24th Feb 20237:00 amRNSNotice of Results
1st Feb 20237:00 amRNSAppointment of Chief Financial Officer
9th Jan 20237:00 amRNSBATM receives $26m cyber security order
3rd Jan 20233:30 pmRNSGrant of Options
21st Dec 202212:00 pmRNSResult of AGM
21st Dec 20227:00 amRNSTransaction in Own Shares and TVR
20th Dec 20227:00 amRNSTransaction in Own Shares and TVR
19th Dec 20227:00 amRNSTransaction in Own Shares and TVR
16th Dec 20227:00 amRNSTransaction in Own Shares and TVR
15th Dec 20227:00 amRNSTransaction in Own Shares and TVR
14th Dec 20227:00 amRNSTransaction in Own Shares and TVR
13th Dec 20227:00 amRNSTransaction in Own Shares and TVR
9th Dec 20227:00 amRNSTransaction in Own Shares and TVR
8th Dec 20227:00 amRNSTrading Update
25th Nov 20221:00 pmRNSBlock Listing Interim Review
24th Nov 20224:00 pmRNSNotice of Annual General Meeting
27th Oct 20227:00 amRNSADOR and BIOASTER to develop STI diagnostic tests
18th Oct 20227:00 amRNSMulti-year contract with CityFibre for Edgility
6th Oct 20227:00 amRNSDirectorate Changes
24th Aug 20227:00 amRNSInterim Results
19th Jul 20227:00 amRNSAppointment of CEO of ADOR Diagnostics
11th Jul 20227:00 amRNSBATM partners with CityFibre for Edgility
16th Jun 20224:36 pmRNSPrice Monitoring Extension
26th May 20227:00 amRNSBlock Listing Interim Review
14th Apr 20229:30 amRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.